Replies to post #375947 on Amarin Corp Plc (AMRN)

[dukesking]

Thanks Raf. GV still increased by approx 5-6k scripts. This better be a wake up call for KM/BOD.

[rafunrafun]

Scripts for week ending April 29, 2022

Drug Industry TRx: +0.2% w/w; +10.1% y/y

Vascepa
TRx 66,991; -0.3% (-197) w/w; -20.3% y/y
NRx 31,263; -0.3% (-107) w/w; -18.3% y/y
Ref 35,728; -0.2% (-89) w/w; -22.1% y/y

Lovaza (Generic & Brand)
TRx 63,662; +2.1% (+1,282) w/w; +3.2% y/y
NRx 31,790; +0.9% (+270) w/w; +4.0% y/y
Ref 31,872; +3.3% (+1,012) w/w; +2.3% y/y

Generic Vascepa
TRx 36,111; +0.0% (+1) w/w; As % of total V: 35.0%
NRx 20,753; +0.7% (+137) w/w; As % of total V: 39.9%
Ref 15,357; -0.9% (-136) w/w; As % of total V: 30.1%

Generic Vascepa by Manufacturer
Hikma - TRx 7,408; (+835) w/w; Generic share 20.5%; Total V share 7.2%
Reddy - TRx 18,566; (+284) w/w; Generic share 51.4%; Total V share 18.0%
Apotex - TRx 10,136; (-1,120) w/w; Generic share 28.1%; Total V share 9.8%

Vascepa + Generic Vascepa
TRx 103,102; -0.2% (-196) w/w; +10.0% y/y
NRx 52,017; +0.1% (+30) w/w; +19.0% y/y
Ref 51,086; -0.4% (-226) w/w; +2.1% y/y